Home » Psychology news » Rapastinel (GLYX-13) shown to improve ketamine or PCP-induced cognitive impairment in mice

Rapastinel (GLYX-13) shown to improve ketamine or PCP-induced cognitive impairment in mice

January 20, 2016 by

Allergan plc, a leading global pharmaceutical company, announced that new data on the investigational medication rapastinel (GLYX-13) and its lack of impairment on cognitive function were published...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>